TG4001 + Avelumab Phase 1b results in HPV16+ R/M cancersTG4001 + Avelumab Phase 1b/2 results in HPV16+ R/M cancersDetailed data of the Phase 1b/2 trial presented at SITC 2020 Read the poster Access the webcast November 2020